Parkless 12.5/50/200 mg

Active Ingredient(s): Carbidopa, Levodopa & Entacapone

Dosage: 12.5 mg / 50 mg / 200 mg

Form & Pack Size: 30 F.C. Tablets

Indication: Treatment of Parkinson’s disease

Description

Parkless provides advanced triple-combination therapy to enhance motor control and manage Parkinson’s disease symptoms smoothly. By combining levodopa, carbidopa, and entacapone, it ensures steady dopamine delivery with reduced end-of-dose fluctuations. Restore mobility and daily independence through specialized neurological innovation.

Reviews

There are no reviews yet.

Be the first to review “Parkless 12.5/50/200 mg”

Your email address will not be published. Required fields are marked *

Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.

Contact Info
Phone: +963986000022
E-Mail: info@zein-pharma.com

© 2026 Zein Pharma. All rights reserved.